Therapeutic drug monitoring of imatinib for chronic myeloid leukemia patients in the chronic phase.
about
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceSimple methodology for the therapeutic drug monitoring of the tyrosine kinase inhibitors dasatinib and imatinib.Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics.Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles.Suppression of carboxylesterases by imatinib mediated by the down-regulation of pregnane X receptor.LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21.LncRNA SNHG5 regulates imatinib resistance in chronic myeloid leukemia via acting as a CeRNA against MiR-205-5p.An Automated Homogeneous Immunoassay for Quantitating Imatinib Concentrations in Plasma.The Interface between BCR-ABL-Dependent and -Independent Resistance Signaling Pathways in Chronic Myeloid Leukemia.Therapeutic drug monitoring of imatinibClinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia.
P2860
Q26865927-00F70351-F71F-4649-9418-9B4288DB758CQ34377463-BB62058E-4817-4823-8AF0-79119C9C04A2Q38207943-1CB5A2DF-3260-4F9E-B764-A846095A197FQ38379295-7C5B6F58-DA5F-4183-A551-B5E994126A19Q38995804-567962D6-6324-4AE7-ADAA-2B0E5988809FQ41498465-87933840-8DD5-4D8F-A35A-7D3E345CEA20Q41547616-5021B679-79F3-4520-A363-CFDCC8D3C606Q41568738-49F21E0E-E757-4F9D-968E-212C8665D8A2Q41842515-CD1D3552-3032-4F7D-9D8A-24D66A55C837Q42269517-8DBB1451-14BA-4377-A400-E883BA26E8F4Q43841175-AB12E9A9-347D-4C8A-AE3F-430AD516D111Q44027139-0FD2BE6A-D3CA-4638-BDE1-B22B12437A4B
P2860
Therapeutic drug monitoring of imatinib for chronic myeloid leukemia patients in the chronic phase.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic drug monitoring of ...... patients in the chronic phase.
@en
Therapeutic drug monitoring of ...... patients in the chronic phase.
@nl
type
label
Therapeutic drug monitoring of ...... patients in the chronic phase.
@en
Therapeutic drug monitoring of ...... patients in the chronic phase.
@nl
prefLabel
Therapeutic drug monitoring of ...... patients in the chronic phase.
@en
Therapeutic drug monitoring of ...... patients in the chronic phase.
@nl
P2860
P356
P1433
P1476
Therapeutic drug monitoring of ...... patients in the chronic phase.
@en
P2093
Masatomo Miura
Naoto Takahashi
P2860
P304
P356
10.1159/000324900
P577
2011-04-06T00:00:00Z